Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,772 signal articles · 76 in last 24h · 148,324 total before filter · latest 52m ago
76last 24h
977last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst12
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Affirm Holdings, Inc. (AFRM) Stock a Buy After Goldman Sachs Raised Its Price Target?
Insider Monkey8h agobullish
Is Affirm Holdings, Inc. (AFRM) Stock a Buy After Goldman Sachs Raised Its Price Target?

Affirm Holdings, Inc. (NASDAQ:AFRM) has underperformed the broader market year to date, but the tide is slowly turning. Robust growth in interest-bearing loans, a strategic partnership with Shopify in Australia, and accelerating volumes at Amazon provide multiple avenues for continued growth. On September 12, Goldman Sachs raised its price target to $115 from $106, citing […]

Strong Operational Momentum Drives Quanta Services’ (PWR) Full-Year Outlook Upgrade
Insider Monkey2d agobullish
Strong Operational Momentum Drives Quanta Services’ (PWR) Full-Year Outlook Upgrade

Reaves W H & Co Inc’s second-quarter 2026 investor letter reports a 10.55% increase for its “Reaves Long Term Value Wrap Strategy,” outperforming the MSCI USA Infrastructure Index’s 6.31% decline. The letter can be downloaded here. Cash distributions grew 6.7% in the quarter compared to Q2 2025. Despite geopolitical uncertainty, investor sentiment remained strong. AI […]

Corning (GLW) Rallied on Strong Long-Term Outlook Upgrade
Insider Monkey2d agobullish
Corning (GLW) Rallied on Strong Long-Term Outlook Upgrade

Reaves W H & Co Inc’s second-quarter 2026 investor letter reports a 10.55% increase for its “Reaves Long Term Value Wrap Strategy,” outperforming the MSCI USA Infrastructure Index’s 6.31% decline. The letter can be downloaded here. Cash distributions grew 6.7% in the quarter compared to Q2 2025. Despite geopolitical uncertainty, investor sentiment remained strong. AI […]

Duolingo’s AI Upgrade And Insider Sale Might Change The Case For Investing In Duolingo (DUOL)
Simply Wall St.2d agobullish
Duolingo’s AI Upgrade And Insider Sale Might Change The Case For Investing In Duolingo (DUOL)

Earlier this week, Duolingo highlighted new AI-driven learning tools and the integration of former Max features into its core Super subscription at Citi’s 2026 Global TMT Conference, while a pre-planned stock sale by General Counsel Stephen C. Chen reduced but did not eliminate his shareholding. The combination of advanced AI features moving into the main subscription tier and continued insider ownership offers fresh context for how Duolingo is evolving its product and governance...

Wave Of Bullish Analyst Upgrades Might Change The Case For Investing In Comfort Systems USA (FIX)
Simply Wall St.3d agobullish
Wave Of Bullish Analyst Upgrades Might Change The Case For Investing In Comfort Systems USA (FIX)

Recently, analysts have clustered around bullish views on Comfort Systems USA, with an average brokerage recommendation between Strong Buy and Buy and a Zacks Rank #1 (Strong Buy) grounded in positive earnings estimate revisions. This wave of favorable analyst sentiment, built on upgraded earnings expectations, has become a key driver of investor perception of Comfort Systems USA’s near-term prospects. We’ll now examine how this concentration of Strong Buy recommendations and upgraded...

ExxonMobil’s LNG Ambitions Just Got A Major Upgrade
Insider Monkey3d agobullish
ExxonMobil’s LNG Ambitions Just Got A Major Upgrade

On September 14, ExxonMobil Holdings Corporation (NYSE:XOM) said that it expects its annual LNG sales to reach 50 million tons by 2030, up from its previous target of 40 million tons, and to keep rising beyond the current decade in line with market growth. The company’s bullish guidance is driven by the high LNG demand […]

Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
Insider Monkey3d agobullish
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?

Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc. (NASDAQ:BIIB) and AbbVie Inc. (NYSE:ABBV)’s ratings from Peer Perform, with Wolfe assigning them similar $300 price targets. The firm’s logic in each case was based on a comparable set of factors: pipelines that the market appears to […]